Fluconazole treatment of coccidioidal meningitis in children: Two case reports and a review of the literature

Pediatric Infectious Disease Journal

Volumn 19, Issue 12, 2000, Pages 1204-1208

  Saitoh, Akihiko ^a   Homans, James ^a   Kovacs, Andrea ^a  

^a LAC USC MEDICAL CENTER   (United States)

Author keywords

Coccidioidomycosis; Fluconazole; Hydrocephalus; Intrathecal amphotericin B; Meningitis

Indexed keywords

AMPHOTERICIN B DERIVATIVE; FLUCONAZOLE; KETOCONAZOLE;

ARTICLE; BLOOD BRAIN BARRIER; BRAIN DECOMPRESSION; CASE REPORT; CLINICAL FEATURE; COCCIDIOIDOMYCOSIS; COMPUTER ASSISTED TOMOGRAPHY; DRUG PENETRATION; DRUG SAFETY; HUMAN; HYDROCEPHALUS; MALE; MENINGITIS; PRESCHOOL CHILD; PRIORITY JOURNAL;

ANTIFUNGAL AGENTS; CHILD, PRESCHOOL; COCCIDIOIDES; COCCIDIOIDOMYCOSIS; FLUCONAZOLE; HUMANS; MALE; MENINGITIS, FUNGAL;

EID: 0034529604     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-200012000-00018     Document Type: Article

References (38)

1. The natural history of coccidioidal meningitis: VA-Armed Forces cooperative studies, 1955-1958
2. Coccidioidal meningitis: An analysis of thirty-one cases and review of the literature
3. Amphotericin B in the treatment of coccidioidomycosis
4. Coccidioidal meningitis, the use of amphotericin B in treatment
5. The treatment of coccidioidal meningitis, the use of amphotericin B in a group of 25 patients
6. Coccidioidal meningitis: Intrathecal treatment with hyperbaric amphotericin B
7. Survival improvement in coccidioidal meningitis by high-dose intrathecal amphotericin B
8. Cisternal puncture complications: Treatment of coccidioidal meningitis with amphotericin B
9. Coccidioidomycosis
10. Pharmacokinetics and tissue penetration of fluconazole in humans
11. Fluconazole: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses
12. Fluconazole penetration into cerebrospinal fluid: Implications for treating fungal infections of the central nervous system
13. Pharmacokinetics of fluconazole in cerebrospinal fluid and serum in human coccidioidal meningitis
14. Fluconazole therapy for coccidioidal meningitis: The NIAID-Mycoses Study Group
15. Treatment of coccidioidal meningitis with fluconazole
16. Treatment of coccidioidal meningitis with fluconazole
17. Coccidioidomycosis: New aspects of epidemiology and therapy
18. Coccidioidomycosis
19. Coccidioides immitis
20. Coccidioidomycosis: Arizona, 1990-1995
21. Serology of coccidioidomycosis
22. Computed tomography in cases of coccidioidal meningitis, with clinical correlation
23. Use of radiologic modalities in coccidioidal meningitis
24. MR findings in acute and chronic coccidioidomycosis meningitis
25. Miconazole in the treatment of coccidioidomycosis
26. Imidazole therapy of coccidioidal meningitis in children
27. Amphotericin B and imidazole therapy for coccidioidal meningitis in children
28. High-dose ketoconazole for treatment of fungal infections of the central nervous system
29. Itraconazole therapy for chronic coccidioidal meningitis
30. Fluconazole in meningeal coccidioidomycosis
31. Safety and tolerability of fluconazole in children
32. Pharmacokinetics of fluconazole in pediatric patients
33. Safety and pharmacokinetics of fluconazole in children with neoplastic diseases
34. Fluconazole pharmacokinetics in the cerebrospinal fluid of a child with Candida tropicalis meningitis
35. Adrenal response in children receiving high doses of ketoconazole for systemic coccidioidomycosis
36. Is it ever safe to stop azole therapy for Coccidioides immitis meningitis?
37. Prediction of relapse after treatment of coccidioidomycosis
38. Adequacy of therapy for coccidioidomycosis [Editorial; comment]